Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000601

Drug Information
SynonymsDichlorphenamid; SBB058142; Diclofenamida [INN-Spanish]; Prestwick3_000809; Dichlorophenamide (DCP); Daranide; CHEMBL17; Prestwick0_000809; Oratrol; EINECS 204-440-6; AC1L1F18; UNII-VVJ6673MHY; BSPBio_000677; DB07948; MLS002154010; ZINC00896918; Diclofenamida; Merck Brand of Dichlorphenamide; NCGC00016371-02; Glajust; Diclofenamide; DB01144; Dichlorphenamide (USP); Diclofenamidum [INN-Latin]; BPBio1_000745; Glaumid; LS-30043; Antidrasi; 120-97-8; Llorens Brand of Dichlorphenamide; HMS1570B19; Daranide (TN); Dichlorophenamide; 3,4-Dichloro-5-sulfamylbenzenesulfonamide; Diclofenamidum; I7A; CHEBI:101085; Barastonin; BRN 2703329; NCGC00016371-01; CB 8000; 1,3-Disulfamoyl-4,5-dichlorobenzene; SMR001233338; C07459; BRD-K71499074-001-03-8; 4,5-Dichloro-benzene-1,3-disulfonic acid diamide; Prestwick2_000809; m-Benzenedisulfonamide, 4,5-dichloro-; Diclofenamid; 1,3-Benzenedisulfonamide, 4,5-dichloro-; 4,5-Dichloro-m-benzenedisulfonamide; S2177_Selleck; Diclofenamide (JP15/INN); Glaucol; D004005; Prestwick_1071; FT-0084528; 4,5-Dichloro-1,3-disulfamoylbenzene; 1,3-Disulfamyl-4,5-dichlorobenzene; CAS-120-97-8; 4,5-Dichloro-1,3-benzenedisulfonamide; dichlorphenamide; Dasanide; Dichlorphenamide [BAN]; 2pou; Glauconide; 4,5-dichlorobenzene-1,3-disulfonamide; Glafco; HSDB 3267; MolPort-004-285-635; Dichlofenamide; D00518; CID3038; C6H6Cl2N2O4S2; Prestwick1_000809; SPBio_002598    
IndicationChronic glaucomaApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntiglaucomic Agents    
CAS NumberCAS 120-97-8
PubChem Compound IDCID 3038.    
PubChem Substance IDSID 9662.    
SuperDrug ATC IDS01EC02;    
SuperDrug CAS ID000120978;    
TargetCarbonic anhydraseInhibitor[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 011366 To Reference
Ref 2Bioorg Med Chem. 2009 Jul 15;17(14):5054-8. Epub 2009 May 30.Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. To Reference
Ref 3Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis. J Med Chem. 2009 May 14;52(9):3116-20. To Reference
Ref 4Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem. 2009 Apr 23;52(8):2226-32. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543